Dr. Chaulagain is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2950 Cleveland Clinic Blvd
Weston, FL 33331Phone+1 954-659-5840Fax+1 954-659-5810
Summary
- I completed clinical and research fellowship in Hematology and Oncology at Tufts University, New England Medical Center in Boston, MA with emphasis in malignant hematology/bone marrow transplantation. I am board certified in Internal Medicine, Medical Oncology, and Hematology. My clinical and research interests and expertise include malignant hematology (blood cancers) and more specifically plasma cell diseases such as multiple myeloma and AL amyloidosis.
I also serve on the Board of Directors of the Florida Society of Clinical Oncology (FLASCO) and in the past chaired the clinical practice committee and program committee of FLASCO and currently serve as the secretary of FLASCO. I have been working as a staff hematologist/oncologist in Cleveland clinic since 2014 and currently work as the director of myeloma and amyloidosis program for Cleveland Clinic Florida. I also serve as the director of cancer research for Cleveland Clinic Florida, Weston FL, USA
Education & Training
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
Cook County Health and Hospitals SystemResidency, Internal Medicine, 2005 - 2008
Tribhuvan University Inst of MedicineClass of 2003
Certifications & Licensure
FL State Medical License 2014 - 2026
MA State Medical License 2011 - 2015
IL State Medical License 2005 - 2011
WI State Medical License 2008 - 2011- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Multiple Myeloma Research Fellow Award Multiple Myeloma Research Foundation (MMRF), 2013
Publications & Presentations
PubMed
- How we manage multiple myeloma with clonal hematopoiesis of indeterminate potential (CHIP): a case report.Ludovic Saba, Lewis Nasr, Jorge Manrique-Succar, Julia Diacovo, Chakra Chaulagain
Annals of Translational Medicine. 2024-10-20 - A Real-World Analysis on Access to Triplet and Quadruplet Therapy in Newly Diagnosed Multiple Myeloma Patients in the United States.Ludovic Saba, Chieh-Lin Fu, Hong Liang, Chakra P Chaulagain
Clinical Lymphoma, Myeloma & Leukemia. 2024-10-09 - Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study.Ashraf Z Badros, Laahn Foster, Larry D Anderson Jr, Chakra P Chaulagain, Erin M Pettijohn
Blood. 2024-09-27
Journal Articles
- Clinicopathologic Characteristics of Secondary Squamous Cell Carcinoma of Head and Neck in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation for Hematolo...Kenneth B Miller, Kellie A Sprague, Chakra P Chaulagain, Esha Kaul, Andreas K Klein, Janet Cowan, Nature
Press Mentions
Therapeutic Advancements Help Patients Facing Rare Blood CancerSeptember 28th, 2021- Why Some Myeloma Patients Refuse Stem Cell TransplantDecember 17th, 2023
Professional Memberships
- Member
Other Languages
- Hindi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
